Local cystic fibrosis sufferers now have access to life-changing treatment following the landmark listing of Trikafta on the Pharmaceutical Benefits Scheme (PBS). On April 1, Trikafta became available on the Pharmaceutical Benefits Scheme (PBS) for cystic fibrosis sufferers aged 12 years and older who have at least one common disease mutation. Minister for Health and […]
